Screener
RxSight, Inc. RXST Total Revenue
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by RxSight, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: RxSight, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335153
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue: | ||||
| Product sales | $27,241 | $33,637 | $58,134 | $71,531 |
| License and collaboration revenue | 6,500 | — | 6,500 | — |
| Total revenue | 33,741 | 33,637 | 64,634 | 71,531 |
| Costs and expenses: | ||||
| Cost of sales | 7,855 | 8,447 | 15,250 | 18,013 |
| Selling, general and administrative | 30,419 | 28,976 | 62,274 | 57,611 |
| Research and development | 9,237 | 10,217 | 18,709 | 20,584 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is RxSight, Inc.'s total revenue?
- RxSight, Inc. (RXST) reported total revenue of $33.74M in Q2 2026.
- How has RxSight, Inc.'s total revenue changed year-over-year?
- RxSight, Inc.'s total revenue increased by 0.3% year-over-year, from $33.64M to $33.74M.
- What is the long-term trend for RxSight, Inc.'s total revenue?
- Over 4 years (2021 to 2025), RxSight, Inc.'s total revenue has grown at a 56.2% compound annual growth rate (CAGR), from $22.59M to $134.48M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about RxSight, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude